Global Parkinsons Disease Drug Sales Market Report 2016

October 2016 | 122 pages | ID: G4BC2EF3350EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Parkinsons Disease Drug

Revenue, means the sales value of Parkinsons Disease Drug

This report studies sales (consumption) of Parkinsons Disease Drug in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Merck
• Akorn
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Kyowa Hakko Kirin Pharma
• Orion
• Stada Arzneimittel
• Valeant
• Apokyn

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Parkinsons Disease Drug in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Parkinsons Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Parkinsons Disease Drug Sales Market Report 2016

1 PARKINSONS DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Classification of Parkinsons Disease Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Parkinsons Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Parkinsons Disease Drug Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Parkinsons Disease Drug (2011-2021)
  1.5.1 Global Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
  1.5.2 Global Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL PARKINSONS DISEASE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Parkinsons Disease Drug Market Competition by Manufacturers
  2.1.1 Global Parkinsons Disease Drug Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Parkinsons Disease Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Parkinsons Disease Drug (Volume and Value) by Type
  2.2.1 Global Parkinsons Disease Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Parkinsons Disease Drug (Volume and Value) by Regions
  2.3.1 Global Parkinsons Disease Drug Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Parkinsons Disease Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Parkinsons Disease Drug (Volume) by Application

3 USA PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 USA Parkinsons Disease Drug Sales and Value (2011-2016)
  3.1.1 USA Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  3.1.2 USA Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  3.1.3 USA Parkinsons Disease Drug Sales Price Trend (2011-2016)
3.2 USA Parkinsons Disease Drug Sales and Market Share by Manufacturers
3.3 USA Parkinsons Disease Drug Sales and Market Share by Type
3.4 USA Parkinsons Disease Drug Sales and Market Share by Application

4 CHINA PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Parkinsons Disease Drug Sales and Value (2011-2016)
  4.1.1 China Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  4.1.2 China Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  4.1.3 China Parkinsons Disease Drug Sales Price Trend (2011-2016)
4.2 China Parkinsons Disease Drug Sales and Market Share by Manufacturers
4.3 China Parkinsons Disease Drug Sales and Market Share by Type
4.4 China Parkinsons Disease Drug Sales and Market Share by Application

5 EUROPE PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Parkinsons Disease Drug Sales and Value (2011-2016)
  5.1.1 Europe Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  5.1.2 Europe Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Parkinsons Disease Drug Sales Price Trend (2011-2016)
5.2 Europe Parkinsons Disease Drug Sales and Market Share by Manufacturers
5.3 Europe Parkinsons Disease Drug Sales and Market Share by Type
5.4 Europe Parkinsons Disease Drug Sales and Market Share by Application

6 JAPAN PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Parkinsons Disease Drug Sales and Value (2011-2016)
  6.1.1 Japan Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  6.1.2 Japan Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Parkinsons Disease Drug Sales Price Trend (2011-2016)
6.2 Japan Parkinsons Disease Drug Sales and Market Share by Manufacturers
6.3 Japan Parkinsons Disease Drug Sales and Market Share by Type
6.4 Japan Parkinsons Disease Drug Sales and Market Share by Application

7 INDIA PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Parkinsons Disease Drug Sales and Value (2011-2016)
  7.1.1 India Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  7.1.2 India Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  7.1.3 India Parkinsons Disease Drug Sales Price Trend (2011-2016)
7.2 India Parkinsons Disease Drug Sales and Market Share by Manufacturers
7.3 India Parkinsons Disease Drug Sales and Market Share by Type
7.4 India Parkinsons Disease Drug Sales and Market Share by Application

8 SOUTHEAST ASIA PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Parkinsons Disease Drug Sales and Value (2011-2016)
  8.1.1 Southeast Asia Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Parkinsons Disease Drug Sales Price Trend (2011-2016)
8.2 Southeast Asia Parkinsons Disease Drug Sales and Market Share by Manufacturers
8.3 Southeast Asia Parkinsons Disease Drug Sales and Market Share by Type
8.4 Southeast Asia Parkinsons Disease Drug Sales and Market Share by Application

9 GLOBAL PARKINSONS DISEASE DRUG MANUFACTURERS ANALYSIS

9.1 GSK
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Parkinsons Disease Drug Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Novartis
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 122 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 145 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Teva Pharmaceutical
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Sept Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Abbvie
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Merck
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Akorn
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Astellas Pharma
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Desitin Arzneimittel
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Endo Pharmaceuticals
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 F.Hoffmann-La Roche
9.12 H.Lundbeck
9.13 Kyowa Hakko Kirin Pharma
9.14 Orion
9.15 Stada Arzneimittel
9.16 Valeant
9.17 Apokyn

10 PARKINSONS DISEASE DRUG MAUFACTURING COST ANALYSIS

10.1 Parkinsons Disease Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Parkinsons Disease Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Parkinsons Disease Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PARKINSONS DISEASE DRUG MARKET FORECAST (2016-2021)

14.1 Global Parkinsons Disease Drug Sales, Revenue Forecast (2016-2021)
14.2 Global Parkinsons Disease Drug Sales Forecast by Regions (2016-2021)
14.3 Global Parkinsons Disease Drug Sales Forecast by Type (2016-2021)
14.4 Global Parkinsons Disease Drug Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons Disease Drug
Table Classification of Parkinsons Disease Drug
Figure Global Sales Market Share of Parkinsons Disease Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Parkinsons Disease Drug
Figure Global Sales Market Share of Parkinsons Disease Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure China Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Japan Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure India Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Global Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
Figure Global Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Parkinsons Disease Drug Sales of Key Manufacturers (2011-2016)
Table Global Parkinsons Disease Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Parkinsons Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinsons Disease Drug Sales Share by Manufacturers
Table Global Parkinsons Disease Drug Revenue by Manufacturers (2011-2016)
Table Global Parkinsons Disease Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Parkinsons Disease Drug Revenue Share by Manufacturers
Table 2016 Global Parkinsons Disease Drug Revenue Share by Manufacturers
Table Global Parkinsons Disease Drug Sales and Market Share by Type (2011-2016)
Table Global Parkinsons Disease Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure Global Parkinsons Disease Drug Sales Growth Rate by Type (2011-2016)
Table Global Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
Table Global Parkinsons Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure Global Parkinsons Disease Drug Revenue Growth Rate by Type (2011-2016)
Table Global Parkinsons Disease Drug Sales and Market Share by Regions (2011-2016)
Table Global Parkinsons Disease Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Sales Growth Rate by Regions (2011-2016)
Table Global Parkinsons Disease Drug Revenue and Market Share by Regions (2011-2016)
Table Global Parkinsons Disease Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Parkinsons Disease Drug by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Parkinsons Disease Drug Sales and Market Share by Application (2011-2016)
Table Global Parkinsons Disease Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Application (2011-2016)
Figure Global Parkinsons Disease Drug Sales Growth Rate by Application (2011-2016)
Figure USA Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure USA Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure USA Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table USA Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table USA Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table USA Parkinsons Disease Drug Sales by Type (2011-2016)
Table USA Parkinsons Disease Drug Market Share by Type (2011-2016)
Table USA Parkinsons Disease Drug Sales by Application (2011-2016)
Table USA Parkinsons Disease Drug Market Share by Application (2011-2016)
Figure China Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure China Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure China Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table China Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table China Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table China Parkinsons Disease Drug Sales by Type (2011-2016)
Table China Parkinsons Disease Drug Market Share by Type (2011-2016)
Table China Parkinsons Disease Drug Sales by Application (2011-2016)
Table China Parkinsons Disease Drug Market Share by Application (2011-2016)
Figure Europe Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Europe Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Europe Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Europe Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table Europe Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table Europe Parkinsons Disease Drug Sales by Type (2011-2016)
Table Europe Parkinsons Disease Drug Market Share by Type (2011-2016)
Table Europe Parkinsons Disease Drug Sales by Application (2011-2016)
Table Europe Parkinsons Disease Drug Market Share by Application (2011-2016)
Figure Japan Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Japan Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Japan Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Japan Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table Japan Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table Japan Parkinsons Disease Drug Sales by Type (2011-2016)
Table Japan Parkinsons Disease Drug Market Share by Type (2011-2016)
Table Japan Parkinsons Disease Drug Sales by Application (2011-2016)
Table Japan Parkinsons Disease Drug Market Share by Application (2011-2016)
Figure India Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure India Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure India Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table India Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table India Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table India Parkinsons Disease Drug Sales by Type (2011-2016)
Table India Parkinsons Disease Drug Market Share by Type (2011-2016)
Table India Parkinsons Disease Drug Sales by Application (2011-2016)
Table India Parkinsons Disease Drug Market Share by Application (2011-2016)
Figure Southeast Asia Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Sales by Manufacturers (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Market Share by Manufacturers (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Sales by Type (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Market Share by Type (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Sales by Application (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Market Share by Application (2011-2016)
Table GSK Basic Information List
Table GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Parkinsons Disease Drug Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Parkinsons Disease Drug Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Parkinsons Disease Drug Global Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Parkinsons Disease Drug Global Market Share (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Parkinsons Disease Drug Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Parkinsons Disease Drug Global Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Akorn Parkinsons Disease Drug Global Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Parkinsons Disease Drug Global Market Share (2011-2016)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Desitin Arzneimittel Parkinsons Disease Drug Global Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Endo Pharmaceuticals Parkinsons Disease Drug Global Market Share (2011-2016)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F.Hoffmann-La Roche Parkinsons Disease Drug Global Market Share (2011-2016)
Table H.Lundbeck Basic Information List
Table H.Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure H.Lundbeck Parkinsons Disease Drug Global Market Share (2011-2016)
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Global Market Share (2011-2016)
Table Orion Basic Information List
Table Orion Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Orion Parkinsons Disease Drug Global Market Share (2011-2016)
Table Stada Arzneimittel Basic Information List
Table Stada Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Stada Arzneimittel Parkinsons Disease Drug Global Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Parkinsons Disease Drug Global Market Share (2011-2016)
Table Apokyn Basic Information List
Table Apokyn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Apokyn Parkinsons Disease Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drug
Figure Manufacturing Process Analysis of Parkinsons Disease Drug
Figure Parkinsons Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinsons Disease Drug
Table Distributors/Traders List
Figure Global Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Parkinsons Disease Drug Sales Forecast by Regions (2016-2021)
Table Global Parkinsons Disease Drug Sales Forecast by Type (2016-2021)
Table Global Parkinsons Disease Drug Sales Forecast by Application (2016-2021)